Joel Greenblatt Supernus Pharmaceuticals, Inc. Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 37,793 shares of SUPN stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

37,793

Previous 11,051 241.99%

Holding current value

$1.35 Million

Previous $295,000 299.32%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.77 - $35.16 $689,141 - $940,248	26,742 Added 241.99%	37,793 $1.18 Million
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $105,155 - $136,957	4,046 Added 57.76%	11,051 $295,000
Q1 2024 May 15, 2024	BUY	$27.11 - $35.17 $189,905 - $246,365	7,005 New	7,005 $238,000
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $262,938 - $340,475	8,791 New	8,791 $264,000
Q2 2022 Aug 15, 2022	SELL	$25.33 - $34.25 $259,987 - $351,542	-10,264 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$28.51 - $32.9 $28,795 - $33,229	-1,010 Reduced 8.96%	10,264 $332,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $28,927 - $37,539	1,097 Added 10.78%	11,274 $329,000
Q3 2021 Nov 15, 2021	BUY	$23.54 - $31.39 $239,566 - $319,456	10,177 New	10,177 $271,000
Q3 2020 Nov 16, 2020	SELL	$20.2 - $25.05 $218,402 - $270,840	-10,812 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$17.09 - $24.89 $583,914 - $850,416	-34,167 Reduced 75.96%	10,812 $257,000
Q1 2020 May 15, 2020	SELL	$14.45 - $24.69 $541,412 - $925,084	-37,468 Reduced 45.44%	44,979 $809,000
Q4 2019 Feb 14, 2020	SELL	$19.93 - $29.13 $420,582 - $614,730	-21,103 Reduced 20.38%	82,447 $1.96 Million
Q3 2019 Nov 14, 2019	BUY	$25.47 - $33.37 $114,029 - $149,397	4,477 Added 4.52%	103,550 $2.85 Million
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $443,647 - $575,586	14,808 Added 17.57%	99,073 $3.28 Million
Q1 2019 May 15, 2019	BUY	$32.77 - $41.99 $1.47 Million - $1.89 Million	44,913 Added 114.13%	84,265 $2.95 Million
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $964,891 - $1.55 Million	31,287 Added 387.94%	39,352 $1.31 Million
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $72,120 - $95,512	1,689 Added 26.49%	8,065 $406,000
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $1.16 Million - $1.58 Million	-26,405 Reduced 80.55%	6,376 $382,000
Q1 2018 May 15, 2018	SELL	$37.15 - $46.9 $3.97 Million - $5.01 Million	-106,816 Reduced 76.52%	32,781 $1.5 Million
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $1.05 Million - $1.23 Million	-28,939 Reduced 17.17%	139,597 $5.56 Million
Q3 2017 Nov 14, 2017	BUY	$36.75 - $49.65 $6.19 Million - $8.37 Million	168,536	168,536 $6.74 Million

Others Institutions Holding SUPN

# of Institutions

281

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account